EMBECTA CORP. Accounts Payable
EMBECTA CORP. (EMBC) had Accounts Payable of $64.30 million as of 2022-06-30, per its 10-Q filed 2022-08-15.
Discontinued › Balance Sheet › Liabilities
us-gaap:AccountsPayableCurrent · last filed 2022-08-15
- 2022-06-30: Accounts Payable, Current $64.30M.
- 2022-03-31: Accounts Payable, Current $50.80M.
- 2021-12-31: Accounts Payable, Current $58.10M.
- 2021-09-30: Accounts Payable, Current $54.20M.
| Period end | Accounts Payable, Current |
|---|---|
| 2022-06-30 | $64.30M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $50.80M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $58.10M 10-Q · filed 2022-03-16 |
| 2021-09-30 | $54.20M 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |